Cost-Effectiveness of Switching to the Nonavale...

By Rene Pretorius

January 13, 2025

A recent study on the cost-effectiveness of transitioning from the bivalent human papillomavirus vaccine (2vHPV) to the nonavalent vacci...
Reevaluating NICE’s Cost-Effectiveness Thresholds: The QALY Debate
Canada’s Drug Agency Launches Consultation on New Methods Guide for Hea...
Healthcare for Older Adults in Türkiye: A Call for Reform
Oman Healthcare Development: A Vision for Self-Reliance and Innovation
Diabetes Management and Economic Burden in Saudi Arabia
CHEERS-AI Economic Evaluation
Overview of NICE’s Elranatamab Managed Access Agreement
Enhancing Child Mental Health Services with Digital Interventions
Strategic Phased Launch of Tirzepatide for Obesity Treatment in England
The Role of School-Based Health Centres in Advancing Health Equity
Mental Health Planning with System Dynamics Modelling in Australia
Cost-Effectiveness of Integrated Care for Children with Chronic Conditions